Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, cash reserves at Immunotech Biopharm Ltd fell by 6.29m. Cash Flow from Financing totalled 273.92m or -- of revenues. In addition the company used 163.63m for operations while cash used for investing totalled 116.60m.
Cash flow per share | -0.5301 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1715 |
---|---|
Tangible book value per share | 0.1262 |
More ▼
Balance sheet in CNYView more
Current ratio | 0.3781 |
---|---|
Quick ratio | 0.3638 |
Total debt/total equity | 1.52 |
---|---|
Total debt/total capital | 0.6119 |
More ▼